TREM2 and neoplasm: Therefore, the genetic deletion (SiRNA) and pharmacological inhibition (blocking ApoEA interaction with TREM2) of these senescent-like MICs, including neutrophils suppresses tumor progression in different mouse models of prostate cancers [49].